Export

ATC codes: H02AB06
EMLc
Indication
Burkitt lymphoma including Burkitt leukaemia ICD11 code: 2B55.6
INN
Prednisolone
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Liquid: 5 mg per mL (EMLc)
Oral > Solid: 5 mg ; 25 mg
EML status history
First added in 2011 (TRS 965)
Changed in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
Medicines within the same pharmacological class can be used
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for prednisolone on the complementary list of the EML and EMLc for use in treatment protocols for Burkitt lymphoma was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for Burkitt lymphoma is attached.